-
Markets
-
Equities
Sustainable finance2025 Euronext ESG Trends ReportRead moreA data-driven snapshot of how Euronext-listed companies are advancing their Environmental, Social and Governance (ESG) practices.
-
Indices
Access the white paperInvesting in the future of Europe with innovative indicesRead moreThe first edition of the Euronext Index Outlook series with a particular focus on the European Strategic Autonomy Index.
-
ETFs
The European market place for ETFsEuronext ETF EuropeRead moreInvestors benefit from a centralised market place that will not only bring transparency but also better pricing due to the grouping of liquidity.
- Funds
-
Fixed Income
European Defence BondsGroupe BPCE lists the first bondRead moreFirst financial institution in Europe to issue a bond dedicated to the defence sector
- Structured Products
-
Derivatives
Where European Government Bonds Meet the FutureFixed Income derivativesRead moreTrade mini bond futures on main European government bonds
-
Commodities
- Overview
- Quotes snapshot
- Power Derivatives
- Milling Wheat derivatives
- Corn derivatives
- Spread contracts
- Rapeseed derivatives
- Durum Wheat derivatives
- Salmon derivatives
- Delivery & settlement
- Specifications & arrangements
- Commitments of Traders (CoT) report
- Commodity brokers
Building a sustainable and liquid power derivatives market.Euronext Nord Pool Power FuturesRead moreEuronext and Nord Pool, the European power exchange, announced the launch of a dedicated Nordic and Baltic power futures market.
-
Resources
Designed to help students navigate the complexities of financial marketsEuronext Trading gameRead moreJoin the Euronext Trading Game and step into capital markets. Learn from today’s leaders, explore sustainable opportunities, and trade with confidence.
Invitation to presentation of Thor Medical ASA's 1H 2025 on Friday 29 August at 08:00
22 Aug 2025 08:00 CEST
Issuer
Thor Medical ASA
22.8.2025 08:00:01 CEST | Thor Medical ASA | Non-regulatory press releases
Thor Medical ASA will present its financial results for the first half 2025 on
Friday 29 August 2025 at 08:00 am (CET) at Sjølyst Møtesenter, Drammensveien
165, and welcome investors, analysts and media to review the company's
achievements in the first half and its vision for the road ahead.
The interim financial report for the first half 2025 and the presentation
material will be released one hour earlier, at 07:00 (CET), and the material
will also be available on the company website at www.thormedical.com -
http://www.thormedical.com.
While Thor Medical encourages physical attendance, the presentation and Q&A
session will also be available through a live webcast at www.thormedical.com -
http://www.thormedical.com or through the following link: Thor Medical Webcast
1H 2025 - https://channel.royalcast.com/hegnarmedia/#!/hegnarmedia/20250829_1
Contacts:
Brede Ellingsæter, CFO & COO, Thor Medical ASA, +47 472 38 440,
brede.ellingseter@thormedical.com
About Thor Medical:
Thor Medical is an emerging supplier of radionuclides, primarily alpha particle
emitters, from naturally occurring thorium. Its proprietary production process
requires no irradiation or use of nuclear reactors, and provides reliable,
environmentally friendly, cost-efficient supply of alpha-emitters for the
radiopharmaceutical industry. Thor Medical is headquartered in Oslo, Norway and
listed on the Oslo Stock Exchange under the ticker symbol 'TRMED'. To learn
more, visit www.thormedical.com - http://www.thormedical.com
ATTACHMENTS
Download announcement as PDF.pdf -
https://kommunikasjon.ntb.no/ir-files/17848634/18627716/6362/Download%20announce
ment%20as%20PDF.pdf
More information:
Access the news on Oslo Bors NewsWeb site
Source
Thor Medical ASA
Provider
Oslo Børs Newspoint
Company Name
THOR MEDICAL ASA
ISIN
NO0010597883
Symbol
TRMED
Market
Euronext Oslo Børs